Clinically Ineffective Reperfusion After Endovascular Therapy in Acute Ischemic Stroke

Stroke. 2023 Mar;54(3):873-881. doi: 10.1161/STROKEAHA.122.038466. Epub 2022 Dec 7.

Abstract

Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large vessel occlusion. However, in clinical practice, nearly half of the patients do not have favorable outcomes despite successful recanalization of the occluded artery. This unfavorable outcome can be defined as having clinically ineffective reperfusion. The objective of the review is to describe clinically ineffective reperfusion after endovascular therapy and its underlying risk factors and mechanisms, including initial tissue damage, cerebral edema, the no-reflow phenomenon, reperfusion injury, procedural features, and variations in postprocedural management. Further research is needed to more accurately identify patients at a high risk of clinically ineffective reperfusion after endovascular therapy and to improve individualized periprocedural management strategies, to increase the chance of achieving favorable clinical outcomes.

Keywords: edema; ischemic stroke; no; reflow phenomenon; reperfusion; risk factors.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Ischemia* / diagnostic imaging
  • Brain Ischemia* / surgery
  • Endovascular Procedures* / adverse effects
  • Humans
  • Ischemic Stroke* / etiology
  • Reperfusion
  • Stroke* / diagnostic imaging
  • Stroke* / surgery
  • Thrombectomy
  • Treatment Outcome